Market Share of Clinical Data Analytics Industry
The clinical data analytics market is semi-consolidated and has gained a competitive edge in recent years. In terms of market share, a few significant players currently dominate the market. These market leaders are focusing on expanding their customer base in foreign countries. These businesses leverage strategic collaborative initiatives to increase their market share and profitability.
- July 2024 - EQT announced that the EQT Healthcare Growth Strategy and the EQT Growth Fund had reached an agreement to purchase a controlling interest in CluePoints. CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in clinical trials, aimed at facilitating safer and more effective processes and enhancing data integrity and risk compliance. This recent investment arrives as CluePoints experiences rapid growth, supported by the rising utilization of RBQM software in nearly all clinical trial stages.
- October 2023 – Holmusk and Veradigm announced a new phase of strategic investment to fuel innovation and close the evidence gap in behavioral health. The collaboration seeks to draw on the strengths of each company to fuel innovation in behavioral health and create the evidence needed to move the field forward. In this new phase of the collaboration, cohorts of millions of behavioral health patients and related de-identified clinical data from Veradigm will be added to Holmusk’s NeuroBlu Database, a leading source for real-world data that shows how behavioral health care is delivered.
Clinical Data Analytics Market Leaders
-
IBM Corporation
-
Oracle Corporation
-
Inspirata Inc.
-
Allscripts Healthcare, LLC
-
SAS Institute, Inc.
*Disclaimer: Major Players sorted in no particular order